Selection and Management of the Lung Donor

Clinics in Chest Medicine

Volumn 32, Issue 2, 2011, Pages 223-232

  Snell, Gregory I ^a   Westall, Glen P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Donor; Donor lung assessment; Lung transplant; Management

Indexed keywords

AGE; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER DONOR; DONOR SELECTION; GRAFT RECIPIENT; HUMAN; LIVING DONOR; LUNG HEMODYNAMICS; LUNG PERFUSION; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PATIENT ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

DONOR SELECTION; HUMANS; LIVING DONORS; LUNG TRANSPLANTATION; ORGAN PRESERVATION; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 79954603824     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.02.002     Document Type: Review

References (77)

1. Williams T.J., Snell G.I. Organ procurement-strategies to optimize donor availability. Semin Respir Crit Care Med 2001, 22(5):541-550.
2. Botha P., Rostron A.J., Fisher A.J., et al. Current strategies in donor selection and management. Semin Thorac Cardiovasc Surg 2008, 20(2):143-151.
3. Snell G.I., Griffiths A., Levvey B.J., et al. Availability of lungs for transplantation: exploring the real potential of the donor pool. J Heart Lung Transplant 2008, 27(6):662-667.
4. Sundaresan S., Trachiotis G.D., Aoe M., et al. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993, 56(6):1409-1413.
5. Yamane M., Sano Y., Toyooka S., et al. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Transplantation 2008, 86(12):1767-1770.
6. Bando T., Date H., Minami M., et al. First registry report: lung transplantation in Japan: the Japanese Society of Lung and Heart-Lung Transplantation. Gen Thorac Cardiovasc Surg 2008, 56(1):17-21.
7. Stamenkovic S., Van Raemdonck D., Verleden G., et al. Bilateral lobar lung transplantation-the first two cases in Belgium. Acta Chir Belg 2007, 107(2):201-204.
8. Keating D.T., Westall G.P., Marasco S.F., et al. Paediatric lobar lung transplantation: addressing the paucity of donor organs. Med J Aust 2008, 189(3):173-175.
9. Sweet S.C., Wong H.H., Webber S.A., et al. Pediatric transplantation in the United States, 1995-2004. Am J Transplant 2006, 6(5 Pt 2):1132-1152.
10. Levvey B. Excellent early results of Australian DCD lung transplantation. J Heart Lung Transplant 2010, 31(2):S63-S64.
11. Kootstra G., Daemen J.H., Oomen A.P. Categories of non-heart-beating donors. Transplant Proc 1995, 27(5):2893-2894.
12. Snell G.I., Levvey B.J., Oto T., et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008, 8(6):1282-1289.
13. Mason D.P., Thuita L., Alster J.M., et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008, 136(4):1061-1066.
14. Tyden G., Kumlien G., Genberg H., et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005, 5(1):145-148.
15. Nelson P.W., Bryan C.F. When will real benefits for minority patients be realized with A2->B transplants?. Transplantation 2010, 89(11):1310-1311.
16. Banner N.R., Rose M.L., Cummins D., et al. Management of an ABO-incompatible lung transplant. Am J Transplant 2004, 4(7):1192-1196.
17. Pierson R.N., Loyd J.E., Goodwin A., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002, 74(1):79-84.
18. Struber M., Warnecke G., Hafer C., et al. Intentional ABO-incompatible lung transplantation. Am J Transplant 2008, 8(11):2476-2478.
19. Sano Y., Aoe M., Date H., et al. Minor ABO-incompatible living-related lung transplantation. Transplant Proc 2002, 34(7):2807-2809.
20. Orens J.B., Boehler A., de Perrot M., et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003, 22(11):1183-1200.
21. Van Raemdonck D., Neyrinck A., Verleden G.M., et al. Lung donor selection and management. Proc Am Thorac Soc 2009, 6(1):28-38.
22. Snell G.I., Westall G.P. Donor selection and management. Curr Opin Organ Transplant 2009, 14(5):471-476.
23. Pierre A.F., Sekine Y., Hutcheon M.A., et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002, 123(3):421-427. [discussion: 7-8].
24. Botha P., Trivedi D., Weir C.J., et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006, 131(5):1154-1160.
25. Meers C., Van Raemdonck D., Verleden G.M., et al. The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int 2010, 23(6):628-635.
26. Levvey B. The lung allocation score in a non-US lung transplant program. J Heart Lung Transplant 2009, 29(2):S135.
27. Gabbay E., Williams T.J., Griffiths A.P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999, 160(1):265-271.
28. Snell G.I., Griffiths A., Macfarlane L., et al. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant 2000, 19(4):401-407.
29. Oto T., Levvey B.J., Whitford H., et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 2007, 83(1):257-263.
30. Iribarne A., Russo M.J., Davies R.R., et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest 2009, 135(4):923-928.
31. Reyes K.G., Mason D.P., Thuita L., et al. Guidelines for donor lung selection: time for revision?. Ann Thorac Surg 2010, 89(6):1756-1764. [discussion: 64-5].
32. Organ Procurement and Transplant Network 2006 Annual Report Available at:, Accessed December 9, 2007. http://www.optn.org/AR2006.
33. Deaths in Australia. Government House, Canberra Australia: Australian Bureau of Statistics Annual Report; 2008. p. 9-10.
34. Opdam H.I., Silvester W. Potential for organ donation in Victoria: an audit of hospital deaths. Med J Aust 2006, 185(5):250-254.
35. Ojo A.O., Wolfe R.A., Leichtman A.B., et al. A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation 1999, 67(4):548-556.
36. Meyers B.F., Patterson G.A. Current status of lung transplantation. Adv Surg 2000, 34:301-318.
37. De Perrot M., Waddell T.K., Shargall Y., et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007, 133(2):525-531.
38. Penn I., Halgrimson C.G., Starzl T.E. De novo malignant tumors in organ transplant recipients. Transplant Proc 1971, 3(1):773-778.
39. Chen F., Karolak W., Cypel M., et al. Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme. J Heart Lung Transplant 2009, 28(10):1116-1118.
40. Armanios M.Y., Grossman S.A., Yang S.C., et al. Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro Oncol 2004, 6(3):259-263.
41. Chen H., Shah A.S., Girgis R.E., et al. Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol 2008, 26(19):3284-3285.
42. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991, 23(5):2629-2631.
43. Bajaj N.S., Watt C., Hadjiliadis D., et al. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int 2010, 23(7):e26-e31.
44. Gandhi M.J., Strong D.M. Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007, 8(4):267-286.
45. Kauffman H.M., Cherikh W.S., McBride M.A., et al. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007, 84(2):272-274.
46. Bonde P.N., Patel N.D., Borja M.C., et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006, 25(1):99-105.
47. Avlonitis V.S., Krause A., Luzzi L., et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003, 24(4):601-607.
48. Mattner F., Kola A., Fischer S., et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection 2008, 36(3):207-212.
49. Len O., Gavalda J., Blanes M., et al. Donor infection and transmission to the recipient of a solid allograft. Am J Transplant 2008, 8(11):2420-2425.
50. Palacios G., Druce J., Du L., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008, 358(10):991-998.
51. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003, 348(22):2196-2203.
52. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005, 352(11):1103-1111.
53. Halpern S.D., Shaked A., Hasz R.D., et al. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008, 358(26):2832-2837.
54. Dhillon G.S., Levitt J., Mallidi H., et al. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database. Transplantation 2009, 88(6):842-846.
55. Shitrit A.B., Kramer M.R., Bakal I., et al. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation. Ann Thorac Surg 2006, 81(5):1851-1852.
56. Oto T., Excell L., Griffiths A.P., et al. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant 2008, 27(1):78-85.
57. Ferraro P., Martin J., Dery J., et al. Late retrograde perfusion of donor lungs does not decrease the severity of primary graft dysfunction. Ann Thorac Surg 2008, 86(4):1123-1129.
58. Steen S., Sjoberg T., Pierre L., et al. Transplantation of lungs from a non-heart-beating donor. Lancet 2001, 357(9259):825-829.
59. Ingemansson R., Eyjolfsson A., Mared L., et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009, 87(1):255-260.
60. Cypel M., Yeung J.C., Hirayama S., et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008, 27(12):1319-1325.
61. Kaneda H., Waddell T.K., de Perrot M., et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006, 6(3):544-551.
62. Anraku M., Cameron M.J., Waddell T.K., et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study. Am J Transplant 2008, 8(10):2140-2148.
63. Ray M., Dharmarajan S., Freudenberg J., et al. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007, 7(10):2396-2405.
64. Avlonitis V.S., Fisher A.J., Kirby J.A., et al. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003, 75(12):1928-1933.
65. Avlonitis V.S., Wigfield C.H., Golledge H.D., et al. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007, 7(1):83-90.
66. Oto T., Excell L., Griffiths A.P., et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant 2008, 8(10):2132-2139.
67. Cooper D.K. Hormonal resuscitation therapy in the management of the brain-dead potential organ donor. Int J Surg 2008, 6(1):3-4.
68. Shah V.R. Aggressive management of multiorgan donor. Transplant Proc 2008, 40(4):1087-1090.
69. Venkateswaran R.V., Patchell V.B., Wilson I.C., et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008, 85(1):278-286. [discussion: 86].
70. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003, 75(4):482-487.
71. Rostron A.J., Avlonitis V.S., Cork D.M., et al. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation 2008, 85(4):597-606.
72. Breathing life into injured lungs: world-first technique will expand lung donor organ pool Available at:, Accessed October 4, 2009. http://insciences.org/article.php%3farticle_id%3d944.
73. Pilcher D.V., Scheinkestel C.D., Snell G.I., et al. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg 2005, 129(4):912-918.
74. Currey J., Pilcher D.V., Davies A., et al. Implementation of a management guideline aimed at minimizing the severity of primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg 2010, 139(1):154-161.
75. UK transplant annual report 2006 Available at:, Accessed December 9, 2007. http://www.uktransplant.org.
76. Eurotransplant International Foundation Annual Report 2009 Available at:, Accessed June 3, 2010. http://wwweurotransplantorg/files/annual_report/ar_2009pdf.
77. Australian and New Zealand Dialysis and Transplant Registry 2009 report Available at:, Accessed June 3, 2010. http://wwwanzdataorgau/v1/report_2009html.